Sintilimab for the treatment of non-small cell lung cancer

Overview of attention for article published in Biomarker Research, April 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 7,455 followers.

RT @pulmonary_news: Researchers provide an overview of sintilimab-based clinical trials on #NSCLC, and may support further investigation of…

Researchers provide an overview of sintilimab-based clinical trials on #NSCLC, and may support further investigation of sintilimab in future clinical trials. Read the #review here: https://t.co/kDjtH1fyZv https://t.co/jBQkYoc1TD

Sintilimab for the treatment of non-small cell lung cancer https://t.co/oc0M1f9Awq

Sintilimab for the treatment of non-small cell lung cancer #lymphoma #lymsm https://t.co/WgLZlxW2QR

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.